Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10081 | 1030 | 35.6 | 78% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CRTH2 | Author keyword | 90 | 72% | 7% | 70 |
2 | MOL BEHAV BIOL | Address | 76 | 47% | 12% | 119 |
3 | PROSTAGLANDIN D 2 | Author keyword | 52 | 38% | 10% | 108 |
4 | DP RECEPTOR | Author keyword | 39 | 80% | 2% | 24 |
5 | LIPOCALIN TYPE PROSTAGLANDIN D SYNTHASE | Author keyword | 35 | 76% | 2% | 25 |
6 | PROSTAGLANDIN D SYNTHASE | Author keyword | 30 | 55% | 4% | 37 |
7 | PGD2 | Author keyword | 27 | 43% | 5% | 48 |
8 | DP1 RECEPTOR | Author keyword | 27 | 83% | 1% | 15 |
9 | BETA TRACE | Author keyword | 25 | 73% | 2% | 19 |
10 | L PGDS | Author keyword | 17 | 70% | 1% | 14 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CRTH2 | 90 | 72% | 7% | 70 | Search CRTH2 | Search CRTH2 |
2 | PROSTAGLANDIN D 2 | 52 | 38% | 10% | 108 | Search PROSTAGLANDIN+D+2 | Search PROSTAGLANDIN+D+2 |
3 | DP RECEPTOR | 39 | 80% | 2% | 24 | Search DP+RECEPTOR | Search DP+RECEPTOR |
4 | LIPOCALIN TYPE PROSTAGLANDIN D SYNTHASE | 35 | 76% | 2% | 25 | Search LIPOCALIN+TYPE+PROSTAGLANDIN+D+SYNTHASE | Search LIPOCALIN+TYPE+PROSTAGLANDIN+D+SYNTHASE |
5 | PROSTAGLANDIN D SYNTHASE | 30 | 55% | 4% | 37 | Search PROSTAGLANDIN+D+SYNTHASE | Search PROSTAGLANDIN+D+SYNTHASE |
6 | PGD2 | 27 | 43% | 5% | 48 | Search PGD2 | Search PGD2 |
7 | DP1 RECEPTOR | 27 | 83% | 1% | 15 | Search DP1+RECEPTOR | Search DP1+RECEPTOR |
8 | BETA TRACE | 25 | 73% | 2% | 19 | Search BETA+TRACE | Search BETA+TRACE |
9 | L PGDS | 17 | 70% | 1% | 14 | Search L+PGDS | Search L+PGDS |
10 | CRTH2 ANTAGONIST | 17 | 75% | 1% | 12 | Search CRTH2+ANTAGONIST | Search CRTH2+ANTAGONIST |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | D SYNTHETASE | 161 | 82% | 9% | 93 |
2 | PROSTAGLANDIN D 2 RECEPTOR | 74 | 79% | 5% | 48 |
3 | RECEPTOR CRTH2 | 69 | 96% | 2% | 22 |
4 | CRTH2 | 69 | 68% | 6% | 60 |
5 | D SYNTHASE | 65 | 64% | 6% | 64 |
6 | BETA TRACE | 65 | 66% | 6% | 60 |
7 | PROSTANOID DP RECEPTOR | 31 | 74% | 2% | 23 |
8 | CRTH2 RECEPTOR | 24 | 91% | 1% | 10 |
9 | PROSTAGLANDIN D 2 | 22 | 26% | 7% | 71 |
10 | DP RECEPTOR | 21 | 71% | 2% | 17 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs | 2014 | 7 | 41 | 80% |
Antagonism of the prostaglandin D-2 receptors DP1 and CRTH2 as an approach to treat allergic diseases | 2007 | 128 | 100 | 58% |
DP2 receptor antagonists in development | 2010 | 34 | 34 | 82% |
Novel CRTH2 antagonists: a review of patents from 2006 to 2009 | 2010 | 28 | 57 | 91% |
CRTH2 and D-Type Prostanoid Receptor Antagonists as Novel Therapeutic Agents for Inflammatory Diseases | 2010 | 44 | 139 | 63% |
Prostaglandin D-2 and sleep/wake regulation | 2011 | 29 | 65 | 62% |
Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis | 2011 | 69 | 371 | 26% |
Emerging roles of DP and CRTH2 in allergic inflammation | 2006 | 90 | 73 | 68% |
Recent Advances in the Discovery and Development of CRTh2 Antagonists | 2011 | 12 | 27 | 89% |
Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase | 2000 | 191 | 94 | 74% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL BEHAV BIOL | 76 | 47% | 12% | 119 |
2 | C PIER | 13 | 71% | 1.0% | 10 |
3 | HUMAN GENE SCI | 5 | 22% | 2.0% | 21 |
4 | ADV MED DEV | 5 | 34% | 1.1% | 11 |
5 | OSAKA BIOSCI | 3 | 35% | 0.6% | 6 |
6 | MENTAL HLTH ENVIRONM EFFECTS | 2 | 40% | 0.4% | 4 |
7 | UNIT PHYSIOL CHEM | 2 | 16% | 1.0% | 10 |
8 | ANIM RADIOL | 2 | 33% | 0.4% | 4 |
9 | SECT CLIN IMMUNOL ALLERGY P DIS | 1 | 33% | 0.3% | 3 |
10 | BIODEF REGULAT | 1 | 16% | 0.6% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000166725 | ONO 1301//IP RECEPTOR//EP4 RECEPTOR |
2 | 0.0000141702 | CYCLOPENTENONE PROSTAGLANDINS//DELTA12 PROSTAGLANDIN J2//DELTA 12 PROSTAGLANDIN J2 |
3 | 0.0000098904 | LEUKOTRIENE C 4 SYNTHESIS DEFICIENCY//HADASSAH MED PHARMACOL//EICOSATETRAYNOIC ACID |
4 | 0.0000090219 | MPGES 1//PROSTAGLANDIN E SYNTHASE//MPGES 2 |
5 | 0.0000085795 | ADRENOMEDULLARY OUTFLOW//PROGRAM NEURAL INTEGRAT//BRAIN PHOSPHOLIPASE A2 |
6 | 0.0000062273 | THROMBOXANE A2 RECEPTOR//THROMBOXANE RECEPTOR//THROMBOXANE A2 |
7 | 0.0000058631 | NEUROINFLAMMAT S//MOL NEUROSCI UNIT//BUTAPROST |
8 | 0.0000050063 | MED BIOCHEM KURAMOTO CHO//4 ACETOXY 2 4 METHYLPHENYLBENZOTHIAZOLE//PHARMACEUT S KITA KU |
9 | 0.0000047295 | EXPT THER EUT PHARMACOINFORMAT//PROSTACYCLIN SYNTHASE GENE//PROSTACYCLIN SYNTHASE |
10 | 0.0000046402 | POLAROGRAPHIC BEHAVIOR//PUBERTY ADOLESCENCE//SODIUM PENTOBARBITAL INDUCED SLEEP |